Gluten in Medicine Disclosure Act of 2013

Bill: 113-hr-2003
Sponsor: full_name: Rep. Ryan, Tim [D-OH-13]
Introduced: 2013-05-15
Policy area: Health
Subjects: Consumer affairs

Drug safety, medical device, and laboratory regulation

Grain

Nutrition and diet

Prescription drugs
Latest action: action_date: 2013-05-17
text: Referred to the Subcommittee on Health.

Summaries:
action_date: 2013-05-15
action_desc: Introduced in House
text: <p>Gluten in Medicine Disclosure Act of 2013 - Amends the Federal Food, Drug, and Cosmetic Act to deem to be misbranded any drug intended for human use that contains an ingredient (other than a polyol) that constitutes or is derived from a grain or starch-containing ingredient and whose label fails to include a parenthetical statement identifying the source of the ingredient so constituted or derived.</p>

tv_txt: I 113th CONGRESS 1st Session H. R. 2003 IN THE HOUSE OF REPRESENTATIVES May 15, 2013 Mr. Ryan of Ohio (for himself and Mrs. Lowey ) introduced the following bill; which was referred to the Committee on Energy and Commerce A BILL To amend the Federal Food, Drug, and Cosmetic Act to require the label of drugs intended for human use to contain a parenthetical statement identifying the source of any ingredient constituting or derived from a grain or starch-containing ingredient.

1. Short title This Act may be cited as the Gluten in Medicine Disclosure Act of 2013 . 2. Labeling of source of human drug ingredients constituting or derived from a grain or starch-containing ingredient (a) Misbranding Section 502 of the Federal Food, Drug, and Cosmetic Act ( 21 U.S.C. 352 ) is amended by adding at the end the following: (bb) If it is a drug— (1) that is intended for human use; (2) that contains an ingredient (other than a polyol) that constitutes or is derived from a grain or starch-containing ingredient; and (3) whose label fails to include a parenthetical statement identifying the source of the ingredient so constituted or derived. . (b) Applicability Section 502(bb) of the Federal Food, Drug, and Cosmetic Act, as added by subsection (a) of this section, shall apply beginning on the sooner of— (1) a date to be determined by the Secretary of Health and Human Services; and (2) the date that is 2 years after the date of the enactment of this Act.